Louisiana MPJE review

Who may transfer a prescription for controlled substance in schedules II, III, or IV.

Pharmacist only.

"The transfer is communicated directly between two licensed pharmacists..."

Title 46 - Professional and Occupational Standards - Part LIII - Chapter 25 - 2523

In an emergency, where the presciber is unavailable, a pharmacist may dispense an emergency fill for how long?

72-hour supply.

Title 46 - Professional and Occupational Standards - Part LIII - Chapter 25 - 2521

True or False: an oral prescription must be reduced to writing prior to entry into a computer system.

False.

"As an alternative to recording such prescriptions on paper forms, a pharmacist may enter the prescription information directly into the pharmacy's dispensing information system"

Title 46 - Professional and Occupational Standards - Part LIII - Chapter 25 - 2511

For a controlled substance with refills, the pharmacist may make what adjustments to dispensing quantity.

Allowed - partial fills

Prohibited - dispensing any more than prescribed quantity (can not combine refills)

Title 46 - Professional and Occupational Standards - Part LIII - Chapter 25 - 2519

Minimum staffing requirement for a telepharmacy

1 certified pharmacy technician

--- 2 years of experience

--- demonstrated proficiency with telepharmacy system

Title 46 - Professional and Occupational Standards - Part LIII - Chapter 24 - 2425

A chart order is considered a prescription drug order if it contains which information

1. PATIENT - full name

2. Date of issue

3. DRUG - name, strength, and dosage form

4. Directions

5. PRACTITIONER - Name

6. Signature (practitioner or designee)

LRS Title 37 Chapter 14 - Pharmacy practice act

True or False: compounding includes preparing drugs in advance of receiving a prescription order based on regularly observed prescribing patterns

True

LRS Title 37 Chapter 14 - Pharmacy practice act

Elements of a "Drug Regimen Review"

Review of the prescription drug order and patient record for:

1. Allergies

2. Therapy contraindications

3. Dose and Route of administration

4. Directions

5. Duplication of therapy

6. Drug interactions

7. Over/under-utilization

LRS Title 37 Chapter 14 - Pharmacy practice act

Reference for source for interchangeability of biologic products

Lists of licensed biologic products with reference product exclusivity and biosimilarity and interchangeability evaluations. (Purple Book)

LRS Title 37 Chapter 14 - Pharmacy practice act

Final checks of work

the requirement that only a pharmacist supervises and releases the completed product prepared by a pharmacy technician.

LRS Title 37 Chapter 14 - Pharmacy practice act

An individual is considered a pharmacy intern under what circumstances.

1. in board approved college of pharmacy and working under supervision of rph

2. graduate

3. qualified applicant awaiting examination for licensure

4. resident or fellow

LRS Title 37 Chapter 14 - Pharmacy practice act

Number of members on the board

17

Make up of board members

16 pharmacists

- 2 from each of the pharmacy districts

1 representative of consumers at large

Who appoints board members

The Governor (Senate must confirm)

Qualifications to be a member of the board (pharmacist)

1. State resident for 6 months

2. Licensed in state

3. Actively practicing and own a permitted pharmacy

4. 2 years experience

5. no felonies, no license probation

Qualifications to be consumer representative on board

1. State resident for year

2 Never licensed by any of the licensing boards, nor spouse

3. No felonies

4. No material financial interest in healthcare profession

Term length for board members (pharmacists)

6 years beginning July 1 of year appointed. (and until a successor is appointed)

term length for consumer representative on board

Serves "at the pleasure of the governor"

How often must board meet?

"at least every 12 months"

LRS Title 37 Chapter 14 - Pharmacy practice act

Qualifications to be licensed by examination

1. AGE - 21

2. "GOOD MORAL CHARACTER"

3. EDUCATION (either)

----a. graduated from approved college

----b. graduated from foreign college, completed transcript verification program, passed college of pharmacy equivalency exam program, completed communication ability testing.

4. 1 year minimum of professional internship experience

5. EXAMS - all required by board

6. FEES - all required by board

7. Criminal background check

8. Completed application

LRS Title 37 Chapter 14 - Pharmacy practice act

True or False: Failing the MPJE or another state 3 times renders a candidate ineligible for taking the MPJE of Louisiana.

True. (will have to satisfy requirements of the board)

Qualifications for reciprocity

1. AGE - 21 years

2. GOOD MORAL CHARACTER

3. have qualifications at time of licensure in OG state to have been eligible for licensure in LA.

4. OG license in active status

5. Presented any evidence of any disciplinary action, arrests, conviction taken by any other jurisdiction, board.

6. Passed all examinations by board

7. Paid all fees required

8. Completed application

Upon successful completion of all requirements for reciprocity the board shall license the pharmacist within ______ .

14 days

How often are individual licenses to be renewed?

Annually

The board shall assess on each annual pharmacist license renewal a fee of ______ as a "pharmacy education support fee", which is allocated to a public university in the state.

100 dollars

LRS Title 37 Chapter 14 - Pharmacy practice act

A pharmacist may administer an influenza immunization to any person _____ years of age or older without a prescription or medical order.

7

A pharmacist should report each influenza immunization to ______ .

The Louisiana Office of Public Health

A pharmacist should report all adverse events observed or reported related to an immunization to ______ .

Vaccine Adverse Events Reporting System (VAERS) program of the CDC.

LRS Title 37 Chapter 14 - Pharmacy practice act

A record or each immunization must be retained for how long

2 years

LRS Title 37 Chapter 14 - Pharmacy practice act

Upon administering a non-influenza immunization according to the administration protocol by the CDC and ACIP, the pharmacist shouldreport the immunization to _______.

the Department of Health, office of public health's Louisiana Immunization Network for Kids Statewide.

Prior to administering a non-influenza immunization according to the administration protocol by the CDC and ACIP, the pharmacist should ask the patient for _______

the patient's Primary Care Provider's name. The Rph shall notify the provider as soon as reasonably possible after an immunization is administered.

LRS Title 37 Chapter 14 - Pharmacy practice act

True or False: a pharmacy or pharmacist may refuse to provide service if reimbursement is less than acquisition cost of a drug, service, etc.

True

True or False: After a pharmacist or tech as complied with all duties required by law, a cashier or clerk may lawfully deliver the drug and collect payment.

True

LRS Title 37 Chapter 14 - Pharmacy practice act

True or False: Electronic transfer of prescriptions are permitted even when a pharmacy is not open for business

True

LRS Title 37 Chapter 14 - Pharmacy practice act

When all refills on an original prescription have been dispensed, additional refills may be added provided that...

may not be transferred to the patient or patient's representative prior to the receipt of an authorization from the prescriber.

Date and time of authorization and name of person authorizing must be documented. (retrievable in hard copy within 72 hours of a request)

LRS Title 37 Chapter 14 - Pharmacy practice act

A prescription label shall contain which pieces of information?

1. Rx number

2. Pharmacist initials - review, filling, dispensing,

3. Directions (unless pbr says no)

4. Date of fill

5. Name of pharmacy

6. Trade name or generic name (unless pbr says no)

7. Patient name

LRS Title 37 Chapter 14 - Pharmacy practice act - 1225/1226

A list of the names of all pharmacists dispensing medication shall be posted in the pharmacy for viewing by ________ .

employees

No later than _____ after dispensing a biological product, the pharmacist or designee shall communicate to the pbr the specific product provided to the patient, including name and manufacturer.

5 days

(may be done by any means)

(not required if a refill which is unchanged from prior filling)

(not required if pbr writes DAW)

LRS Title 37 Chapter 14 - Pharmacy practice act - 1226.1

Drugs may be donated to a charitable pharmacy if meeting which requirements

1. original sealed package or unit-dose packages, or blister packs

2. PIC of charitable pharmacy determines drug is safe to dispense.

3. The donor executes a donation form

4. Donor name, Rx number, other ID'ing info removed from pkg

5. Drug name, strength, exp. date remain on medication pkg label

6. Charitable pharmacy complies with all controlled substance laws.

7. If rejected by charitable pharmacy closest, the donor may then donate to Dept. of Public Safety and Corrections.

8. No expired drugs can be dispensed

LRS Title 37 Chapter 14 - Pharmacy practice act - 1226.2

Chart orders are ongoing until ______ .

the pbr discontinues the order and communicates discontinuation to the pharmacy.

LRS Title 37 Chapter 14 - Pharmacy practice act - 1226.

A pharmacy must retain the records of every prescription filled, compounded or dispensed for _____.

2 years

LRS Title 37 Chapter 14 - Pharmacy practice act - 1229.

An electronic record keeping system must be capable of producing a hard copy printout of the prescription record within _______ of a request.

72 hours.

LRS Title 37 Chapter 14 - Pharmacy practice act - 1229.

Each pharmacy permitted by the board shall renew its permit _______

annually.

All permitted persons must report to the board the occurrence of _______

1. permanent closure

2. change of ownership, mgmt, location, or PIC.

3. Any theft or significant loss

4.Any known conviction of any employee of any state or fed drug laws.

5. Disasters, accidents, or any theft, destruction, or loss of records required to be maintained by state or fed law.

LRS Title 37 Chapter 14 - Pharmacy practice act - 1231.

A non-resident pharmacy must keep records of any controlled substances dispensed to residents of LA so that ______ .

the records are easily retrievable from the records of other drugs dispensed.

LRS Title 37 Chapter 14 - Pharmacy practice act - 1232.

True or False: A patient must be informed about and consent to generic substitution before any such substitution may be performed.

True.

LRS Title 37 Chapter 14 - Pharmacy practice act - 1241.

For the purpose of generic substitution, individuals enrolled in ________ give their implied consent by their participation in the program.

Medicaid

LRS Title 37 Chapter 14 - Pharmacy practice act - 1241.

An military-trained applicant or a military spouse licensed in another jurisdiction may practice as a pharmacist upon the board issuing a _____________ for use while the applicant is satisfying the requirements for licensure in Louisiana.

temporary practice permit

LRS Title 37 Chapter 59 - Licensure for individuals with military training - 3651.

A violation of the Louisiana State Food, Drug, and Cosmetic act by an individual working for a corporation is the liability of ________ .

Both the individual and the corporation

LRS Title 40 chapter 4 - Food and Drugs - 603

A violation of the Louisiana State Food, Drug, and Cosmetic act by an technician employed by a pharmacist is the liability of ________ .

Both the technician and the pharmacist.

"the act or omission of any officer, employee, or agent acting for or employed by any person, within the scope of employment or office, shall in every case be considered the act or omission of such person, as well as that of the officer, employee, or agent"

LRS Title 40 chapter 4 - Food and Drugs - 603

A drug is ADULTERATED if:

1. consists in whole or in part of any filthy, putrid, or decomposed substance

2. Made or held under unsanitary conditions.

3. Container made of poisonous, deleterious substance.

4. Contains coal-tar color, for coloring only, other than from a certified batch.

5. Differs from strength, quality, purity in compendium

6. Mixed with substance that would reduce its quality/strength.

LRS Title 40 chapter 4 - Food and Drugs - 616

A drug is MISBRANDED if:

1. Labeling false or misleading (representations not supported by scientific facts)

2. Dangerous as prescribed or labeled.

3. In package form without

----A. Man, packer, seller, or distrib. - Name, Address

----B. Accurate statement of contents - wgt, count, etc

4. Not labeled "caution: Louisiana Law prohibits dispensing without a prescription" when containing

----A. amyl nitrite

----B. isopentyl nitrite

----C. butyl nitrite

----D. n-butyl nitrite

----E. isobutyl nitrite

5. Not packaged as compendium instructs

6. Liable to deterioration, but not packaged to prevent or labeled to caution against.

7. Misleading container

LRS Title 40 chapter 4 - Food and Drugs - 617

An agent of __________ may enter the pharmacy for an inspection for compliance with the Louisiana State Food, Drug, and Cosmetic Act.

the Louisiana Department of Health

LRS Title 40 chapter 4 - Food and Drugs - 631

True or False: An agent of the Louisiana Department of Health may seize any drug deemed to be misbranded or adulterated from a pharmacy.

True

LRS Title 40 chapter 4 - Food and Drugs - 633

Penalty for first violation of LA Food, Drug, and Cosmetic Act

$1000 or 1 year in jail (or both)

Penalty for a second violation of LA Food, Drug, and Cosmetic Act

$3000 or 2 years in jail (or both)

True or False: The Louisiana Uniform Controlled Dangerous Substances Law does not apply to industrial hemp or CBD products.

True.

LRS Title 40 chapter 4 - Food and Drugs - 961

In Louisiana Tramadol is classified as which schedule of control substance?

IV

The marketing of OTC ephedrine for indication of _________ is prohibited.

stimulation, mental alertness, weight loss, appetite control, energy.

LRS Title 40 chapter 4 - Food and Drugs - 962.1

It is illegal to possess more than _______ of ephedrine, pseudoephedrine, phenylpropanolamine or their salts.

12 grams.

LRS Title 40 chapter 4 - Food and Drugs - 962.1.1

It is illegal to possess ephedrine, pseudoephedrine, phenylpropanolamine or their salts in _________ form unless the weight of the ingredient is less than 12 g and the powder is in the manufacturer's original packaging that can be lawfully sold OTC.

powder

LRS Title 40 chapter 4 - Food and Drugs - 962.1.1

Possession of more than 12 g of ephedrine, pseudoephedrine, or prenylpropanolamine is lawful if contained in a pediatric product that.....

1. Solid form - no more than 15 mg per dosage unit

2. Liquid form - no more than 15mg per 5 ml

3. Liquid form for under 2 years old -

----i. recommended dosage = not more than 2 ml

----ii. total package = not more than 1 fluid ounce.

LRS Title 40 chapter 4 - Food and Drugs - 962.1.1

Dextromethorphan or DM-containing products may not be sold over-the-counter to any person under the age of ____________.

18

LRS Title 40 chapter 4 - Food and Drugs - 962.1.1

Any over-the-counter product containing dextromethorphan may not be sold without the purchaser providing _________.

Valid photo ID issued by Louisiana, another state, of the US government.

LRS Title 40 chapter 4 - Food and Drugs - 962.1.2

In addition to a DEA registration and pharmacy license, a pharmacy in Louisiana that dispenses controlled substances must also obtain __________.

A controlled substance license issued by the Board.

Any prescriber, except a veterinarian, who holds a controlled substance license from the Board, shall also be enrolled in ____________ .

the prescription monitoring program.

LRS Title 40 chapter 4 Part X- Food and Drugs - 973

True or False: a pharmacy with multiple locations must obtain from the Board a controlled substance registration for each location where controlled substances are dispensed.

true.

LRS Title 40 chapter 4 Part X- Food and Drugs - 973

Inventory of controlled substances in schedules I-V must be taken how frequently?

every 2 years.

(although this contradicts

Title 46 - Professional and Occupational Standards - Part LIII - Chapter 15 -1509)

LRS Title 40 chapter 4 Part X- Food and Drugs - 976

How long is a schedule II prescription good for?

90 days.

"No prescription for a Schedule II substance may be refilled nor may such prescription be filled more than ninety days after the date of the prescription"

LRS Title 40 chapter 4 Part X- Food and Drugs - 978

Prescription quantity dispensing limit for schedule II and schedule III opioid derivatives for prescribers not licensed in Louisiana.

10 days.

exception: dispensing pharmacist can view PMP in prescriber's state

exception: prescriber indicates cancer diagnosis or terminally ill.

"The pharmacist shall not dispense more than a ten-day supply at a dosage not to exceed the United States Food and Drug Administration's approved labeling for the medication if the prescriber for such medication is not licensed by the state of Louisiana, and the medication is an opioid derivative Schedule II or an opioid derivative Schedule III controlled dangerous substance"

LRS Title 40 chapter 4 Part X- Food and Drugs - 978(E)

After dispensing a schedule II or schedule III opioid derivative from a prescriber who is not licensed in Louisiana, another dispensing for a schedule II or III opioid from a non-LA prescriber is not permitted for how long?

60 days (unless dispensing pharmacist can view PMP in prescriber's state)

exception: dispensing pharmacist can view PMP in prescriber's state

exception: prescriber indicates cancer diagnosis or terminally ill.

LRS Title 40 chapter 4 Part X- Food and Drugs - 978(E)

A prescriber writing for opioids should check the prescription monitoring program at what points? What exceptions exist?

1. Prior to initial prescribing of any opioid

2. Every 90 days if treatment continues

Exceptions:

1. Hospice or terminally ill

2. For cancer pain

3. For hospital in-patient

4. PMP not accessible due to tech issue.

LRS Title 40 chapter 4 Part X- Food and Drugs - 978(F)

Prescribing limits for first-time opioid use for adult outpatient for acute condition

7-day supply

LRS Title 40 chapter 4 Part X- Food and Drugs - 978(G)

Prescribing limits for opioid use by a minor

7-day supply. First or any subsequent prescription.

LRS Title 40 chapter 4 Part X- Food and Drugs - 978(G)

A prescriber electing to write for more than a 7-day supply of an opioid for an adult or minor must ____________ .

1. Document medical condition necessitating greater than 7-day supply in medical chart

2. Indicate that no non-opioid would suffice

3. Indicate on rx that supply is medically necessary.

LRS Title 40 chapter 4 Part X- Food and Drugs - 978(G)

Medications which are exempt from regulation limiting opioid prescriptions to 7 days

Meds for the treatment of abuse or opioid dependence.

LRS Title 40 chapter 4 Part X- Food and Drugs - 978(G)

True or False: A patient may partially fill a schedule II medication and then later request an additional fill from the same prescription.

True.

LRS Title 40 chapter 4 Part X- Food and Drugs - 978(H)

True or false: A prescriber may issue a prescription for naloxone for a patient without having examined that patient

True.

LRS Title 40 chapter 4 Part X- Food and Drugs - 978.2

True or False: A pharmacist may dispense naloxone or another opioid antagonist pursuant to a nonpatient-specific standing order per Board rules.

True.

LRS Title 40 chapter 4 Part X- Food and Drugs - 978.2

Dispensers must submit which information to the prescription monitoring program for each controlled substance or monitored drug?

1. Prescriber info

2. Patient info

3. Prescription info

4. Controlled substance or drug info.

5. Dispenser info

LRS Title 40 chapter 4 Part X-A - Prescription monitoring program law - 1006

Time to report a dispensing of a controlled substance or monitored drug to the prescription monitoring program

By the next business day after the date of dispensing.

LRS Title 40 chapter 4 Part X-A - Prescription monitoring program law - 1006

Who may access the prescription monitoring program?

1. Prescribers

2. Dispensers

3. Representatives from professional licensing boards or regulatory agencies in LA or other state.

4. Louisiana Medicaid Reps.

5. Vendor who maintains the PMP

6. Licensed substance abuse addiction counselor

7. Probation or parole officer

8. Epidemiologist with LA Dept. of Health

The number of specialty licenses for the purpose of dispensing medical marijuana that the Louisiana Board of pharmacy may issue.

"no more than ten licenses"

LRS Title 40 chapter 4 Part X-E - Therapeutic use of marijuana - 1046

Who may sell ephedrine, pseudoephedrine, or phenylpropanolamine?

1. Pharmacist

2. Pharmacy tech.

3. Pharmacy employee

LRS Title 40 chapter 4 Part X-F - Ephedrine, Pseudoephedrine, and Phenylpropanolamine Monitoring Act - 1049.3

Necessary steps for a sale of ephedrine, pseudoephedrine, or phenylpropanolamine

1. Purchaser produces Federal or state Photo ID

2. Electronic or written log captures

----a. Purchaser signature

----b. Purchaser name AND address

----c. Date

----d. Product sold

----e. Amount sold in packages and total grams

3. Transaction recorded and transmitted to central computer monitoring system

LRS Title 40 chapter 4 Part X-F - Ephedrine, Pseudoephedrine, and Phenylpropanolamine Monitoring Act - 1049.3

Nonprescription Ephedrine or Pseudoephedrine sales limits

9 grams of base ingredient, not salt, per 30 days

True or False: a law enforcement officer may obtain an administrative search warrant to inspect written logs of ephedrine / PSE purchases.

True

LRS Title 40 chapter 4 Part X-F - Ephedrine, Pseudoephedrine, and Phenylpropanolamine Monitoring Act - 1049.3

How frequently must a pharmacy transmit the data for ephedrine / PSE purchases to the central computer monitoring system.

immediately after recording each transaction

LRS Title 40 chapter 4 Part X-F - Ephedrine, Pseudoephedrine, and Phenylpropanolamine Monitoring Act - 1049.4

Which governing body maintains the central computer system for monitoring ephedrine / PSE sales.

Department of Public Safety and Corrections, office of state police.

LRS Title 40 chapter 4 Part X-F - Ephedrine, Pseudoephedrine, and Phenylpropanolamine Monitoring Act - 1049.4

True or False: a pharmacist may continue to complete a sale for ephedrine or PSE even if the central computer system indicates that the purchaser may have exceeded the legal purchasing limits.

True.

LRS Title 40 chapter 4 Part X-F - Ephedrine, Pseudoephedrine, and Phenylpropanolamine Monitoring Act - 1049.8

No legend drug may be manufactured or distributed for sale in Louisiana without __________________ .

an imprint identifying the drug which is clearly marked or imprinted on the dosage form.

LRS Title 40 chapter 4 Part X-VI - Legend Drugs - 1060.12

True or false: a prescriber may issue a prescription for a patient after having the patient complete an electronic questionnaire, without seeing the patient.

False. (physical examination is required)

LRS Title 40 chapter 4 Part X-F - Legend Drugs - 1060.16

True or False: prescribing pursuant to expedited partner therapy for a venereal disease is permitted without a doctor-patient relationship or clinical assessment.

True.

LRS Title 40 chapter 5-B Part X-A - Venereal Diseases (Expedited Partner Therapy) - 1049.4

True or False: a pharmacist may be considered in violation for dispensing a controlled substance to a patient who has signed a voluntary nonopioid form.

False.

LRS Title 40 chapter 5-D Part I-D - Voluntary nonopioid directive - 1049.4

Prescriptions from a physician at a pain management clinic should be written for a period of no longer than ______ .

30 days.

LRS Title 40 chapter 11 Part XII-A - 2198.12

Pharmacy Benefit Managers must register with __________.

The secretary of state.

LRS Title 40 chapter 36

A Pharmacy Benefit Manager must submit a new application if its ownership changes by ___________.

50% or more.

LRS Title 40 chapter 36

How many times may an applicant take an examination for licensure before having to wait a year?

3 times.

Title 46 - Professional and Occupational Standards - Part LIII - Chapter 5.

After a 3rd unsuccessful attempt of an examination for licensure, a candidate has to wait ________ from the date of last examination.

1 year.

Title 46 - Professional and Occupational Standards - Part LIII - Chapter 5.

An application for renewal of a pharmacist license must be received by what date?

December 31 of each year.